| 1 | DVBCWCS3 ;ALB/RLC CUSHING'S SYNDROME WKS TEXT - 1 ; 12 FEB 2007
 | 
|---|
| 2 |  ;;2.7;AMIE;**121**;Apr 10, 1995;Build 9
 | 
|---|
| 3 |  ;
 | 
|---|
| 4 |  ;
 | 
|---|
| 5 | TXT ;
 | 
|---|
| 6 |  ;;A.  Review of Medical Records:
 | 
|---|
| 7 |  ;;
 | 
|---|
| 8 |  ;;B.  Medical History (Subjective Complaints):
 | 
|---|
| 9 |  ;;
 | 
|---|
| 10 |  ;;    Comment on:
 | 
|---|
| 11 |  ;;
 | 
|---|
| 12 |  ;;    1.  Date diagnosis established.
 | 
|---|
| 13 |  ;;    2.  Current symptoms:  weakness, fatigue, weight change, acne, mental
 | 
|---|
| 14 |  ;;        changes, vision problems.
 | 
|---|
| 15 |  ;;    3.  History of glucose intolerance?
 | 
|---|
| 16 |  ;;    4.  Etiology?  Latrogenic?
 | 
|---|
| 17 |  ;;    5.  Treatments (surgery, medication, etc.), dose, frequency, response,
 | 
|---|
| 18 |  ;;        side effects.
 | 
|---|
| 19 |  ;;    6.  Effects of the condition on occupational functioning and daily
 | 
|---|
| 20 |  ;;        activities.
 | 
|---|
| 21 |  ;;    7.  History of hospitalizations or surgery, dates and location, if known,
 | 
|---|
| 22 |  ;;        reason or type of surgery.
 | 
|---|
| 23 |  ;;    8.  History of neoplasm:
 | 
|---|
| 24 |  ;;        
 | 
|---|
| 25 |  ;;        a.  Date of diagnosis, diagnosis.
 | 
|---|
| 26 |  ;;        b.  Benign or malignant.
 | 
|---|
| 27 |  ;;        c.  Types of treatment and dates.
 | 
|---|
| 28 |  ;;        d.  Last date of treatment.
 | 
|---|
| 29 |  ;;
 | 
|---|
| 30 |  ;;C.  Physical Examination (Objective Findings):
 | 
|---|
| 31 |  ;;
 | 
|---|
| 32 |  ;;    Address each of the following and fully describe current findings:
 | 
|---|
| 33 |  ;;
 | 
|---|
| 34 |  ;;    1.  Muscle strength.
 | 
|---|
| 35 |  ;;    2.  Vascular fragility.
 | 
|---|
| 36 |  ;;    3.  Blood Pressure.
 | 
|---|
| 37 |  ;;    4.  Striae, skin thinning.
 | 
|---|
| 38 |  ;;    5.  Weight gain or loss, presence of obesity.
 | 
|---|
| 39 |  ;;    6.  Moonface, buffalo hump.
 | 
|---|
| 40 |  ;;    7.  Vision abnormalities, presence of abnormalities requires evaluation
 | 
|---|
| 41 |  ;;        by vision specialist.
 | 
|---|
| 42 |  ;;    8.  After control, describe adrenal insufficiency, cardiovascular,
 | 
|---|
| 43 |  ;;        psychiatric, skin, or skeletal complications or residuals, follow
 | 
|---|
| 44 |  ;;        appropriate worksheets.
 | 
|---|
| 45 |  ;;
 | 
|---|
| 46 |  ;;D.  Diagnostic and Clinical Tests:
 | 
|---|
| 47 |  ;;
 | 
|---|
| 48 |  ;;    Provide:
 | 
|---|
| 49 |  ;;
 | 
|---|
| 50 |  ;;    1.  CT of brain or X-ray of sella turcica, unless of record.
 | 
|---|
| 51 |  ;;    2.  Serum and urine cortisol levels, unless of record.
 | 
|---|
| 52 |  ;;    3.  High and low dose dexamethasone suppression test, unless of record.
 | 
|---|
| 53 |  ;;    4.  Imaging studies for size of adrenals, unless of record.
 | 
|---|
| 54 |  ;;    5.  Glucose tolerance test, if needed, to confirm glucose intolerance.
 | 
|---|
| 55 |  ;;    6.  X-rays if osteoporosis suspected.
 | 
|---|
| 56 |  ;;    7.  Include results of all diagnostic and clinical tests conducted
 | 
|---|
| 57 |  ;;        in the examination report.
 | 
|---|
| 58 |  ;;
 | 
|---|
| 59 |  ;;E.  Diagnosis:
 | 
|---|
| 60 |  ;;
 | 
|---|
| 61 |  ;;    Comment on:
 | 
|---|
| 62 |  ;;
 | 
|---|
| 63 |  ;;    1.  Is the disease active or in remission?
 | 
|---|
| 64 |  ;;
 | 
|---|
| 65 |  ;;
 | 
|---|
| 66 |  ;;Signature:                             Date:
 | 
|---|
| 67 |  ;;END
 | 
|---|